| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.9× | −1.7× | |
| Price / Book | −22.5× | 2.0× | |
| Price / Sales | 145.4× | 3.9× | |
| Price / Free cash flow | −6.4× | −1.5× | |
| EV / EBITDA | −4.8× | −1.2× | |
| Earnings yield | −52.2% | −14.3% | |
| Free cash flow yield | −15.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,297.95 | +4.64% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $260.41 | +2.61% | $627.56B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.66 | +2.12% | $510.1B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.01 | +2.74% | $375.2B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.24 | +3.21% | $365.73B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.92 | +1.81% | $281.91B | 19.7× | 30.5% |
| +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.39 | +2.71% | $261.16B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $683.29 | +0.58% | $252.64B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $436.18 | +2.65% | $235.81B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.49 | +1.58% | $192.8B | 22.3× | 37.5% | +29.9% |
